- 4.4Impact Factor
- 8.8CiteScore
- 21 daysTime to First Decision
Special Issues
Cancers publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Human Carcinogens—Chemical Agents, Occupational Exposure and Health Impact
Deadline: 31 August 2026
Early Detection and Strategies for Overcoming Therapy Resistance in Lung Cancer and Mesothelioma
Deadline: 31 August 2026
Hypoxia-Targeting Strategies to Improve Cancer Therapy Outcomes
Deadline: 31 August 2026
The Genetic Analysis and Clinical Therapy in Lung Cancer: 2nd Edition
Deadline: 31 August 2026
Clinical Treatment and Outcomes of Gastrointestinal Cancer
Deadline: 31 August 2026
Wnt Signaling Pathway in Cancer Immunotherapy
Deadline: 31 August 2026
CAR T Cell Therapy in Cancer: Progress and Challenges Across Solid and Hematologic Malignancies
Deadline: 31 August 2026
New Advances and Approaches in Thyroid Cancer
Deadline: 31 August 2026
Advances in the Early Diagnosis and Treatment of Gastric Cancer (2nd Edition)
Deadline: 31 August 2026
Tumor Microenvironment in Cancer Therapies: Supportive or Hostile?
Deadline: 31 August 2026
Acute Myeloid Leukemia in Adults (2nd Edition)
Deadline: 31 August 2026
The Unseen Burden: Incidence and Outcomes of Infections in Leukemia
Deadline: 31 August 2026
of 261

